Naslov: | Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : an initiative of the Central European Cooperative Oncology Group (CECOG) |
---|
Avtorji: | ID Thallinger, Christiane (Avtor) ID Berzinec, Peter (Avtor) ID Bicakcic, Emina (Avtor) ID Dan, Adelina (Avtor) ID Fabian, Gabriella (Avtor) ID Gales, Laurentia Nicoletta (Avtor) ID Grašič-Kuhar, Cvetka, Onkološki inštitut (Avtor) ID Janžič, Urška, Klinika Golnik (Avtor) ID Mencinger, Marina, Onkološki inštitut (Avtor) ID Zielinski, Christoph (Avtor) |
Datoteke: | PDF - Predstavitvena datoteka, prenos (1,14 MB) MD5: F6D526A31B618E9D49B935C799F7E617
URL - Izvorni URL, za dostop obiščite https://link.springer.com/content/pdf/10.1007/s00508-022-02016-z.pdf
|
---|
Jezik: | Angleški jezik |
---|
Tipologija: | 1.01 - Izvirni znanstveni članek |
---|
Organizacija: | UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
|
---|
Povzetek: | o establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). Methods: We established and implemented a VTB based on the WebEx platform. This allowed for password-protected and secure upload of patient cases to be presented and discussed among colleagues from various oncology centers scattered throughout CEE in order to arrive at a recommendation for further diagnoses and/or treatment. Results: A total of 73 cases from 16 oncology centers located in 11 CEE countries were uploaded by 22 physicians; 71 were discussed over the course of 17 virtual meetings between June 2018 and May 2019 and 12 different kinds of malignant diseases were discussed with lung cancer (46.6%), melanoma (19.2%) and bladder cancer (13.6%) being the most commonly presented tumor entities. Of the discussed patients, 93.3% had stage IV disease at the time of presentation, 62.6% received chemotherapy or targeted treatment and 67.1% were treated with immune checkpoint inhibitors (ICPIs). The most common causes for presentation and discussion of patient cases were related to the use of ICPIs (80%). Conclusion: When the need for expertise exceeds locally available resources, web-based VTBs provide a feasible way to discuss patient cases and arrive at conclusions regarding diagnoses and/or treatment across large geographic distances. Moreover, VTBs provide an innovative way for proper, state-of-the-art management of patients with malignant diseases in times of social distancing and the resulting need for restricted interaction during the current SARS-CoV‑2 (severe acute respiratory syndrome coronavirus type 2) pandemic. |
---|
Ključne besede: | CECOG, Osrednja in jugovzhodna Evropa, nadzorni imunski zaviralci, maligne bolezni |
---|
Status publikacije: | V tisku |
---|
Verzija publikacije: | Objavljena publikacija |
---|
Kraj izida: | Avstrija |
---|
Založnik: | Springer Nature |
---|
Leto izida: | 2022 |
---|
Št. strani: | str. [1-8] |
---|
Številčenje: | Vol. , no. |
---|
PID: | 20.500.12556/DiRROS-14941 |
---|
UDK: | 616-006 |
---|
ISSN pri članku: | 0043-5325 |
---|
DOI: | 10.1007/s00508-022-02016-z |
---|
COBISS.SI-ID: | 102525955 |
---|
Avtorske pravice: | © The Author(s) |
---|
Opomba: | Soavtorice iz Slovenije: Cvetka Grašič Kuhar, Marina Mencinger, Urška Janžič;
|
---|
Datum objave v DiRROS: | 31.03.2022 |
---|
Število ogledov: | 1079 |
---|
Število prenosov: | 645 |
---|
Metapodatki: | |
---|
:
|
Kopiraj citat |
---|
| | | Objavi na: | |
---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |